Wells Fargo
CLDX icon

Wells Fargo’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$881K Buy
43,276
+9,898
+30% +$201K ﹤0.01% 3432
2025
Q1
$606K Buy
33,378
+880
+3% +$16K ﹤0.01% 3552
2024
Q4
$821K Buy
32,498
+10,087
+45% +$255K ﹤0.01% 3399
2024
Q3
$762K Sell
22,411
-325
-1% -$11K ﹤0.01% 3369
2024
Q2
$841K Buy
22,736
+1,121
+5% +$41.5K ﹤0.01% 3281
2024
Q1
$907K Buy
21,615
+6,861
+47% +$288K ﹤0.01% 3201
2023
Q4
$585K Sell
14,754
-27,075
-65% -$1.07M ﹤0.01% 3419
2023
Q3
$1.15M Sell
41,829
-12,272
-23% -$338K ﹤0.01% 2995
2023
Q2
$1.84M Buy
54,101
+20,516
+61% +$696K ﹤0.01% 2832
2023
Q1
$1.21M Buy
33,585
+32,538
+3,108% +$1.17M ﹤0.01% 3041
2022
Q4
$46.7K Sell
1,047
-1,517
-59% -$67.6K ﹤0.01% 4589
2022
Q3
$73K Sell
2,564
-244
-9% -$6.95K ﹤0.01% 4466
2022
Q2
$75K Sell
2,808
-30,023
-91% -$802K ﹤0.01% 4554
2022
Q1
$1.12M Sell
32,831
-13,881
-30% -$473K ﹤0.01% 3563
2021
Q4
$1.81M Buy
46,712
+26,527
+131% +$1.03M ﹤0.01% 3382
2021
Q3
$1.09M Buy
20,185
+20,036
+13,447% +$1.08M ﹤0.01% 3948
2021
Q2
$5K Sell
149
-20
-12% -$671 ﹤0.01% 5988
2021
Q1
$3K Sell
169
-49,328
-100% -$876K ﹤0.01% 6206
2020
Q4
$866K Buy
49,497
+49,115
+12,857% +$859K ﹤0.01% 4070
2020
Q3
$6K Buy
382
+131
+52% +$2.06K ﹤0.01% 5655
2020
Q2
$3K Sell
251
-79
-24% -$944 ﹤0.01% 5678
2020
Q1
$0 Buy
330
+25
+8% ﹤0.01% 5869
2019
Q4
$0 Buy
305
+80
+36% ﹤0.01% 5892
2019
Q3
$0 Sell
225
-348
-61% ﹤0.01% 5888
2019
Q2
$1K Buy
573
+92
+19% +$161 ﹤0.01% 5771
2019
Q1
$2K Sell
481
-1,843
-79% -$7.66K ﹤0.01% 5696
2018
Q4
$0 Buy
2,324
+1
+0% ﹤0.01% 5873
2018
Q3
$1K Sell
2,323
-3,300
-59% -$1.42K ﹤0.01% 5816
2018
Q2
$3K Sell
5,623
-77,491
-93% -$41.3K ﹤0.01% 5750
2018
Q1
$194K Buy
83,114
+19,432
+31% +$45.4K ﹤0.01% 4808
2017
Q4
$180K Sell
63,682
-22,303
-26% -$63K ﹤0.01% 4825
2017
Q3
$246K Buy
85,985
+7,183
+9% +$20.6K ﹤0.01% 4652
2017
Q2
$195K Sell
78,802
-1,600
-2% -$3.96K ﹤0.01% 4640
2017
Q1
$291K Sell
80,402
-11,997
-13% -$43.4K ﹤0.01% 4439
2016
Q4
$327K Buy
92,399
+14,016
+18% +$49.6K ﹤0.01% 4330
2016
Q3
$317K Buy
78,383
+18,661
+31% +$75.5K ﹤0.01% 4072
2016
Q2
$262K Sell
59,722
-1,417
-2% -$6.22K ﹤0.01% 4132
2016
Q1
$231K Sell
61,139
-501,595
-89% -$1.9M ﹤0.01% 4190
2015
Q4
$8.82M Sell
562,734
-55,133
-9% -$864K ﹤0.01% 1923
2015
Q3
$6.51M Buy
617,867
+161,591
+35% +$1.7M ﹤0.01% 2115
2015
Q2
$11.5M Buy
456,276
+130,638
+40% +$3.29M ﹤0.01% 1795
2015
Q1
$8.99M Sell
325,638
-42,910
-12% -$1.18M ﹤0.01% 1964
2014
Q4
$6.73M Buy
368,548
+322,258
+696% +$5.88M ﹤0.01% 2103
2014
Q3
$600K Sell
46,290
-10,185
-18% -$132K ﹤0.01% 3731
2014
Q2
$922K Sell
56,475
-35,680
-39% -$583K ﹤0.01% 3538
2014
Q1
$1.63M Buy
92,155
+36,642
+66% +$648K ﹤0.01% 3101
2013
Q4
$1.34M Buy
55,513
+31,505
+131% +$763K ﹤0.01% 3197
2013
Q3
$850K Buy
24,008
+20,417
+569% +$723K ﹤0.01% 3432
2013
Q2
$56K Buy
+3,591
New +$56K ﹤0.01% 4518